Aleor Dermaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 8 Year, 8 Months
- Last Filing with ROC 31 Mar 2021
- Satisfied Charges ₹ 300.00 Cr
- Revenue Growth 307.87%
- Profit Growth -12.41%
- Ebitda 16.69%
- Net Worth -109.50%
- Total Assets 11.42%
About Aleor Dermaceuticals
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24302GJ2016PLC092131
- Company No.
092131
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
23 May 2016
- Date of AGM
20 Jul 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Aleor Dermaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dhananjay Wyawahare | CEO | 20-Oct-2020 | Current |
Kevalkumar Thakkar  | Company Secretary | 25-Jul-2019 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mitanshu Shah | Director | 23-May-2016 | Current |
| Rajkumar Baheti | Director | 23-May-2016 | Current |
| Jesal Shah | Director | 23-May-2016 | Current |
Financial Performance of Aleor Dermaceuticals.
Aleor Dermaceuticals Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 307.87% increase. The company also saw a substantial fall in profitability, with a 12.41% decrease in profit. The company's net worth observed a substantial decline by a decrease of 109.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aleor Dermaceuticals?
In 2021, Aleor Dermaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Alembic Pharmaceuticals LimitedRajkumar Baheti is a mutual person
Alembic LimitedKevalkumar Thakkar is a mutual person
Arvind Hebbal Homes Private LimitedMitanshu Shah is a mutual person
- Ashta Therapeutics Private Limited
Jesal Shah is a mutual person
Charges (Loans)
₹0
₹3,000.00 M
Charges Breakdown by Lending Institutions
- Others : 300.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Nov 2016 | Others | ₹300.00 Cr | Satisfied |
How Many Employees Work at Aleor Dermaceuticals?
Aleor Dermaceuticals has a workforce of 245 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aleor Dermaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aleor Dermaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
